SCHEMBL6947669

SCHEMBL6947669

Cc1nc(OCCCCO[Si](C)(C)C(C)(C)C)c([N+](=O)[O-])c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MGMT P16455 2/20 0.40
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.35
HTT P42858 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 2/20 0.34
POLB P06746 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.33
EED O75530 1/20 0.33
HTR1A P08908 1/20 0.32
HTR7 P34969 1/20 0.32
NPY5R Q15761 1/20 0.32
GPR55 Q9Y2T6 1/20 0.32
DUT P33316 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949472 0.86 MGMT (0.42) MGMTMAPTSMN1; SMN2HTTCYP1A2
SCHEMBL6953559 0.85 MAPT (0.49) MGMTMAPTSMN1; SMN2HTTCYP1A2
SCHEMBL6948575 0.84 MGMT (0.42) MGMTMAPTSMN1; SMN2HTTCYP1A2
SCHEMBL6951003 0.83 MGMT (0.42) MGMTMAPTSMN1; SMN2HTTCYP1A2
SCHEMBL6945292 0.83 MGMT (0.45) MGMTMAPTSMN1; SMN2HTTCYP1A2
SCHEMBL6949320 0.83 MGMT (0.39) MGMTMAPTSMN1; SMN2HTTCYP1A2
SCHEMBL6955505 0.83 MGMT (0.47) MGMTMAPTSMN1; SMN2HTTCYP1A2
SCHEMBL6957503 0.82 MGMT (0.44) MGMTMAPTSMN1; SMN2HTTCYP1A2
SCHEMBL6948483 0.82 HRH4 (0.41) MGMTMAPTSMN1; SMN2HTTKMT2A
SCHEMBL6957648 0.81 MGMT (0.39) MGMTMAPTSMN1; SMN2HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed